Table 3.
Position 163 amino acid |
Complementation efficiency* |
Complementation score# |
Recovered as viable phage |
Prohead production§ |
---|---|---|---|---|
Val | = 1.0 | + | (wt) | + |
Ile | 1.0 | + | + | + |
Thr | 1.0 | + | + | + |
Gln | 1.0 | + | + | + |
Cys | 1.0 | + | + | + |
Ala | 1.0 | + | + | + |
Leu | 0.1 | + | + | + |
Met | 0.03 | − | − | + |
Asn | 0.001 | − | − | + |
Ser | 0.001 | − | − | + |
Phe | 0.00003 | − | − | + |
Gly | 0.00001 | − | − | + |
Glu | 0.00001 | − | − | + |
Asp | 0.00001 | − | − | + |
Complementation was done with HK97 phage bearing an amber mutation in gene 5 on a lawn of bacteria with a plasmid expressing the named V163X variant. The efficiency reported is calculated relative to the complementation achieved when using the wild-type plasmid, which is set to “1”.
Complementation of 0.1 or higher was judged to be “+”, lower than 0.1 as “–”.
Prohead production was determined in small scale cultures after induction of gene expression from a plasmid carrying the wild-type gene 4 and the named V163X variant of gene 5.